Worldwide Genetic Variability of the Duffy Binding Protein: Insights into Plasmodium vivax Vaccine Development

被引:30
作者
de Sousa, Tais Nobrega [1 ]
Carvalho, Luzia Helena [1 ]
Alves de Brito, Cristiana Ferreira [1 ]
机构
[1] Ctr Pesquisa Rene Rachou Fiocruz, Lab Malaria, Belo Horizonte, MG, Brazil
来源
PLOS ONE | 2011年 / 6卷 / 08期
关键词
HUMAN MALARIA PARASITE; POPULATION-STRUCTURE; LIGAND DOMAIN; INHIBITORY ANTIBODIES; NATURAL-SELECTION; BLOOD-GROUP; ANTIGEN; INFECTION; POLYMORPHISMS; TRANSMISSION;
D O I
10.1371/journal.pone.0022944
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The dependence of Plasmodium vivax on invasion mediated by Duffy binding protein (DBP) makes this protein a prime candidate for development of a vaccine. However, the development of a DBP-based vaccine might be hampered by the high variability of the protein ligand (DBPII), known to bias the immune response toward a specific DBP variant. Here, the hypothesis being investigated is that the analysis of the worldwide DBPII sequences will allow us to determine the minimum number of haplotypes (MNH) to be included in a DBP-based vaccine of broad coverage. For that, all DBPII sequences available were compiled and MNH was based on the most frequent nonsynonymous single nucleotide polymorphisms, the majority mapped on B and T cell epitopes. A preliminary analysis of DBPII genetic diversity from eight malaria-endemic countries estimated that a number between two to six DBP haplotypes (17 in total) would target at least 50% of parasite population circulating in each endemic region. Aiming to avoid region-specific haplotypes, we next analyzed the MNH that broadly cover worldwide parasite population. The results demonstrated that seven haplotypes would be required to cover around 60% of DBPII sequences available. Trying to validate these selected haplotypes per country, we found that five out of the eight countries will be covered by the MNH (67% of parasite populations, range 48-84%). In addition, to identify related subgroups of DBPII sequences we used a Bayesian clustering algorithm. The algorithm grouped all DBPII sequences in six populations that were independent of geographic origin, with ancestral populations present in different proportions in each country. In conclusion, in this first attempt to undertake a global analysis about DBPII variability, the results suggest that the development of DBP-based vaccine should consider multi-haplotype strategies; otherwise a putative P. vivax vaccine may not target some parasite populations.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Plasmodium vivax DBP Binding to Aotus nancymaae Erythrocytes Is Duffy Antigen Dependent
    McHenry, A. M.
    Barnwell, J. W.
    Adams, J. H.
    [J]. JOURNAL OF PARASITOLOGY, 2010, 96 (01) : 225 - 227
  • [42] Non-allele specific antibody responses to genetically distinct variant forms of Plasmodium vivax Duffy binding protein (PvDBP-II) in Iranians exposed to seasonal malaria transmission
    Valizadeh, Vahideh
    Zakeri, Sedigheh
    Mehrizi, Akram Abouei
    Djadid, Navid Dinparast
    [J]. ACTA TROPICA, 2014, 136 : 89 - 100
  • [43] Sequence analysis of Plasmodium vivax Duffy binding proteins reveals the presence of unique haplotypes and diversifying selection in Ethiopian isolates
    Golassa, Lemu
    Messele, Alebachew
    Oriero, Eniyou Cheryll
    Amambua-Ngwa, Alfred
    [J]. MALARIA JOURNAL, 2021, 20 (01)
  • [44] Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians
    Nicolete, Vanessa C.
    Frischmann, Sarah
    Barbosa, Susana
    King, Christopher L.
    Ferreira, Marcelo U.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (10) : 1539 - 1546
  • [45] A comparative study on worldwide genetic diversity and population structure analysis of Plasmodium vivax thrombospondin-related adhesive protein (PvTRAP) and its implications for the vivax vaccine design
    Nazeri, Saeed
    Mehrizi, Akram Abouie
    Djadid, Navid Dinparast
    Zakeri, Sedigheh
    [J]. INFECTION GENETICS AND EVOLUTION, 2015, 36 : 410 - 423
  • [46] Antibody Responses and Avidity of Naturally Acquired Anti-Plasmodium vivax Duffy Binding Protein (PvDBP) Antibodies in Individuals from an Area with Unstable Malaria Transmission
    Zakeri, Sedigheh
    Babaeekhou, Lalch
    Mehrizi, Akram Abouie
    Abbasi, Maryam
    Djadid, Navid Dinparast
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2011, 84 (06) : 944 - 950
  • [47] Amplification of Duffy binding protein-encoding gene allows Plasmodium vivax to evade host anti-DBP humoral immunity
    Popovici, Jean
    Roesch, Camille
    Carias, Lenore L.
    Khim, Nimol
    Kim, Saorin
    Vantaux, Amelie
    Mueller, Ivo
    Chitnis, Chetan E.
    King, Christopher L.
    Witkowski, Benoit
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [48] Microsatellite loci: determining the genetic variability of Plasmodium vivax
    Rezende, A. M.
    Tarazona-Santos, E.
    Fontes, C. J. F.
    Souza, J. M.
    Couto, A. D'A.
    Carvalho, L. H.
    Brito, C. F. A.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (06) : 718 - 726
  • [49] DEVELOPMENT OF QUANTITATIVE RECEPTOR-LIGAND BINDING ASSAY FOR USE AS A TOOL TO ESTIMATE IMMUNE RESPONSES AGAINST Plasmodium vivax DUFFY BINDING PROTEIN REGION II
    Shakri, Ahmad Rushdi
    Rizvi, M. Moshahid A.
    Chitnis, Chetan E.
    [J]. JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, 2012, 33 (04) : 403 - 413
  • [50] Genetic Diversity and Natural Selection of Plasmodium vivax Duffy Binding Protein-II From China-Myanmar Border of Yunnan Province, China
    Shi, Tian-Qi
    Shen, Hai-Mo
    Chen, Shen-Bo
    Kassegne, Kokouvi
    Cui, Yan-Bing
    Xu, Bin
    Chen, Jun-Hu
    Zheng, Bin
    Wang, Yue
    [J]. FRONTIERS IN MICROBIOLOGY, 2021, 12